Get the Stockscreener App
4.4786
2.13%
0.0934
After Hours:
4.52
0.0414
+0.92%
Pluri Inc stock is traded at $4.4786, with a volume of 5,245.
It is up +2.13% in the last 24 hours and down -9.28% over the past month.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
See More
Previous Close:
$4.3852
Open:
$4.38
24h Volume:
5,245
Relative Volume:
0.52
Market Cap:
$36.53M
Revenue:
$1.03M
Net Income/Loss:
$-21.34M
P/E Ratio:
-0.7253
EPS:
-6.175
Net Cash Flow:
$-18.22M
1W Performance:
+3.91%
1M Performance:
-9.28%
6M Performance:
+17.39%
1Y Performance:
-2.00%
1-Day Range:
$4.31
$4.52
1-Week Range:
$4.08
$4.52
52-Week Range:
$3.33
$7.13
Pluri Inc Stock (PLUR) Company Profile
Name
Pluri Inc
Sector
Industry
Phone
972-74-710-7171
Address
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
Compare PLUR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLUR
Pluri Inc
|
4.4786 | 35.77M | 1.03M | -21.34M | -18.22M | -6.175 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pluri Inc Stock (PLUR) Latest News
Is Pluri Inc. stock a smart buy before Fed meetingDip Buying & Verified Momentum Stock Watchlist - newser.com
Quantitative breakdown of Pluri Inc. recent moveMarket Risk Summary & Weekly High Potential Stock Alerts - newser.com
How Pluri Inc. stock performs in rate cut cyclesEarnings Overview Report & AI Forecasted Entry and Exit Points - newser.com
Trend analysis for Pluri Inc. this weekJuly 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
Will Pluri Inc. price bounce be sustainableEarnings Risk Summary & Community Verified Watchlist Alerts - newser.com
Will Pluri Inc. stock split attract more investorsJuly 2025 Rallies & Fast Exit and Entry Strategy Plans - newser.com
Using RSI to spot recovery in Pluri Inc.Earnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Using Ichimoku Cloud for Pluri Inc. technicals2025 Performance Recap & Weekly High Momentum Picks - newser.com
Is Pluri Inc. reversing from oversold territory2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com
Multi factor analysis applied to Pluri Inc.July 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - newser.com
Candlestick signals on Pluri Inc. stock todayEarnings Growth Summary & Long-Term Safe Return Strategies - newser.com
Institutional scanner results for Pluri Inc.2025 Winners & Losers & Verified Technical Signals - newser.com
Why Pluri Inc. (4DX) stock stays on top picksRate Cut & Reliable Breakout Forecasts - newser.com
Can Pluri Inc. (4DX) stock reach $200 price targetMarket Growth Review & AI Driven Stock Reports - newser.com
Pluri and Instituto del Café de Chiapas partner on cell-based coffee - Comunicaffe International
Pluri Subsidiary Coffeesai and Instituto del Café de Chiapas Announce Strategic Collaboration to Advance Cell-Based Coffee Manufacturing in Mexico - The Manila Times
Pluri subsidiary Coffeasai and Instituto del Cafe de Chiapas collaborate to advance cell-based coffee manufacturing in Mexico - MarketScreener
$250B+ coffee market: Pluri's Coffeesai to develop cell-based coffee in Chiapas under 3-phase roadmap - Stock Titan
Using AI based signals to follow Pluri Inc.Gap Up & High Yield Stock Recommendations - newser.com
Is Pluri Inc. (4DX) stock a safe buy pre earnings2025 Breakouts & Breakdowns & Intraday High Probability Alerts - newser.com
Reversal indicators forming on Pluri Inc. stock2025 Trade Ideas & Real-Time Chart Breakout Alerts - newser.com
Is Pluri Inc. (4DX) stock resilient in recession scenarios2025 Market WrapUp & Growth Focused Stock Reports - newser.com
Is a relief rally coming for Pluri Inc. holdersWall Street Watch & Low Risk High Reward Ideas - newser.com
Pluri Inc Stock Analysis and ForecastGrowth Stock Opportunities & Big Profit Low Trading - earlytimes.in
Is PB Fintech Limited a Top Alpha Generator for Growth PortfoliosEarnings Growth Projections & High Yield Trading Plans - earlytimes.in
What indicators show strength in Pluri Inc.2025 Price Momentum & Weekly High Return Forecasts - newser.com
How Pluri Inc. (4DX) stock reacts to new regulationsMarket Volume Report & Scalable Portfolio Growth Ideas - newser.com
Visual analytics tools that track Pluri Inc. performanceJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
What machine learning models say about Pluri Inc.Weekly Investment Report & Safe Capital Growth Tips - newser.com
Pattern recognition hints at Pluri Inc. upside2025 Price Targets & Daily Market Momentum Tracking - newser.com
Pluri Inc Stock (PLUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):